Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus Transition in Kidney Transplant
NCT02096107Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in kidney transplant rejection, Kidney allograft fibrosis, primary graft dysfunction (PGD), sponsored by Medical University of South Carolina. Started Feb 2014; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejectionKidney allograft fibrosisprimary graft dysfunction (PGD)
Beyond the preview
Go deeper on NCT02096107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02096107.